Dark Forest Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History

Dark Forest Capital Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,222	Closed	-$407K	–	1496
2025 Q1	$407K	Buy	+9,222	New	+$425K	0.02%	987
2023 Q2	–	Sell	-8,910	Closed	-$229K	–	1382
2023 Q1	$229K	Buy	+8,910	New	+$260K	0.05%	331
2022 Q1	–	Sell	-254	Closed	-$16K	–	1741
2021 Q4	$16K	Buy	+254	New	+$16.8K	0.01%	762
2021 Q3	–	Sell	-3,793	Closed	-$313K	–	1538
2021 Q2	$313K	Buy	+3,793	New	+$288K	0.14%	79

Other funds holding SWTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Dark Forest Capital Management's SWTX Position: Q2 2025 in Review

Dark Forest Capital Management sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 9,222 shares — an estimated $407K sold.

Dark Forest Capital Management first reported a position in SWTX in Q2 2021 and held it in 4 quarters. The position peaked at $407K in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

Dark Forest Capital Management reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
Dark Forest Capital Management sold 9,222 SpringWorks Therapeutics shares in Q2 2025, an estimated $407K.
Dark Forest Capital Management first reported a position in SpringWorks Therapeutics in Q2 2021 and held it in 4 quarters.
Dark Forest Capital Management's SpringWorks Therapeutics position peaked at $407K in Q1 2025.
223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Dark Forest Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.